Reaction time in patients with HIV/AIDS and correlation with CD4 count: a case-control study

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 101, Issue 5, 2007, Pages 517-522

  Ogunrin, A O ^a   Odiase, F E ^a   Ogunniyi, A ^b  

^a UNIVERSITY OF BENIN   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

AIDS; CD4 lymphocyte count; HIV; Nigeria; Psychomotor performance; Reaction time

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AFRICA; ARTICLE; ATTENTION DISTURBANCE; CASE CONTROL STUDY; CD4+ T LYMPHOCYTE; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PSYCHOMOTOR ACTIVITY; PSYCHOMOTOR RETARDATION; REACTION TIME; SYMPTOM;

ADULT; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; REACTION TIME;

EID: 33847738449     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2006.10.002     Document Type: Article

References (25)

1. Bacellar H., Munoz A., Miller E.N., Cohen B.A., Besley D., Selnes O.A., Becker J.T., and McArthur J.C. Temporal trends in the incidence of HIV-1-related neurologic disease: Multicenter AIDS Cohort Study, 1985-1992. Neurology 44 (1994) 1892-1900
2. CDC. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm. Rep. 41 RR-17 (1992) 1-19
3. De Cock K.M., and Weiss H.A. The global epidemiology of HIV/AIDS. Trop. Med. Int. Health 5 (2000) A3-A9
4. Epstein L.G., and Gendelman H.E. Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms. Ann. Neurol. 33 (1993) 429-436
5. Ferrando S.J. Diagnosis and treatment of HIV-associated neurocognitive disorders. New Dir. Ment. Health Serv. 87 (2000) 25-35
6. Ferrando S.J., Rabkin J.G., van Gorp W., Lin S.H., and McElhiney M. Longitudinal improvement in psychomotor processing speed is associated with potent combination antiretroviral therapy in HIV-1 infection. J. Neuropsychiatry Clin. Neurosci. 15 (2003) 208-214
7. Heaton R.K., Grant I., Butters N., White D.A., Kirson J.H., Atkinson J.H., McCutchan J.A., Taylor M.J., Kelly M.D., and Ellis R.J. The HNRC 500-neuropsychology of HIV infection at different stages. HIV Neurobehavioural Center. J. Int. Neuropsychol. Soc. 1 (1995) 231-251
8. Marra C.M., Lockhart D., Zunt J.R., Perrin M., Coombs R.W., and Collier A.C. Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy. Neurology 60 (2003) 1388-1390
9. Masliah E., Ge N., and Mucke L. Pathogenesis of HIV-1 associated neurodegeneration. Crit. Rev. Neurobiol. 10 (1996) 57-67
10. Miller E.N., Satz P., and Visscher B.V. Computerized and conventional neuropsychological assessment of HIV-infected homosexual men. Neurology 41 (1991) 1608-1616
11. Moerland M.C., Aldenkamp A.P., and DeAlpherts W.C.J. A neuropsychological test battery for the Apple IIe. Int. J. Man Mach. Stud. 25 (1986) 453-467
12. Nath A. Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J. Infect. Dis. 186 Suppl. 2 (2002) S193-S198
13. Ogunrin O., Adamolekun B., Ogunniyi A., and Aldenkamp A.P. Cognitive functions in Nigerians with newly diagnosed epilepsy. Can. J. Neurol. Sci. 27 (2000) 148-151
14. Perdices M.A., and Cooper D.A. Simple and choice reaction time in patients with human immunodeficiency virus infection. Ann. Neurol. 25 (1989) 460-467
15. Power C., Selnes O.A., Grim J.A., and McArthur J.C. HIV Dementia Scale: a rapid screening test. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 8 (1995) 273-278
16. Sacktor N., Van Heertum R.L., Dooneief G., Gorman J., Khandji A., Marder K., Nour R., Todak G., Stern Y., and Mayeux R. A comparison of cerebral SPECT abnormalities in HIV-positive homosexual men with and without cognitive impairment. Arch. Neurol. 52 (1995) 1170-1173
17. Selnes O.A. Memory loss in persons with HIV/AIDS: assessment and strategies for coping. AIDS Read. 15 (2005) 289-294
18. Selnes O.A., Miller E., McArthur J.C., Gordon B., Munoz A., Sheridan K., Fox R., and Saah A.J. HIV-1 infection: no evidence of cognitive decline during the asymptomatic stages. Neurology 40 (1990) 204-208
19. Selnes O.A., McArthur J.C., Royal III W., Updike M.L., Nance-Sproson T., Concha M., Gordon B., Solomon L., and Vlahov D. HIV infection and intravenous drug use: longitudinal neuropsychological evaluation of asymptomatic subjects. Neurology 42 (1992) 1924-1930
20. Smith C.A., van Gorp W.G., Ryan E.R., Ferrando J., and Rabkin J. Screening subtle HIV-related cognitive dysfunction: the clinical utility of the HIV dementia scale. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 33 (2003) 116-118
21. Tozzi V., Balestra P., Galgani S., Narciso P., Ferri F., Sebastiani G., D'amato C., Affricano C., Pigorini F., Pau F.M., Defelici A., and Benedetto A. Positive and sustained effects of highly active antiretroviral therapy on HIV-associated neurocognitive impairment. AIDS 13 (1999) 1889-1897
22. UNAIDS, 2004. Report on the Global HIV/AIDS Epidemic, July 2004. Joint United Nations Program on HIV/AIDS, Geneva.
23. Unuigbe E., Ogunrin O., and Onyemekeihia R. Neurocognitive performances in Nigerian Africans with chronic renal failure. Nig. J. Health. Biomed. Sci. 3 (2004) 108-111
24. White D.A., Heaton R.K., and Monsch A.U. Neuropsychological studies of asymptomatic human immunodeficiency virus-type-1 infected individuals. The HNRC Group. HIV Neurobehavioural Research Center. J. Int. Neuropsychol. Soc. 1 (1995) 304-315
25. Wilkie F.L., Eisdorfer C., Morgan R., Lowenstein D.A., and Szapoznik J. Cognition in early human immunodeficiency virus infection. Arch. Neurol. 47 (1990) 433-440